Thanks for the responses. I'll look into all of them.
On mine, I think $ABOS continues to strengthen as they get through Phase II with subsequent data potentially causing explosive growth. They are well capitalized.
$PMN is my favorite AD therapeutic (based on the scientific data), but the company still needs to raise their Phase 2 capital which will cause dilution
$KLGDF has a miniscule market cap and a lot of promising property. But no major hits yet. If they do though, it will go crazy. They'll need to finance of course.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.